BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 30800634)

  • 1. Treatment Strategies in Diffuse Midline Gliomas With the H3K27M Mutation: The Role of Convection-Enhanced Delivery in Overcoming Anatomic Challenges.
    Himes BT; Zhang L; Daniels DJ
    Front Oncol; 2019; 9():31. PubMed ID: 30800634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
    Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
    J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convection Enhanced Delivery for Diffuse Intrinsic Pontine Glioma: Review of a Single Institution Experience.
    Tosi U; Souweidane M
    Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32674336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABC Transporter Inhibition Plus Dexamethasone Enhances the Efficacy of Convection Enhanced Delivery in H3.3K27M Mutant Diffuse Intrinsic Pontine Glioma.
    Tsvankin V; Hashizume R; Katagi H; Herndon JE; Lascola C; Venkatraman TN; Picard D; Burrus B; Becher OJ; Thompson EM
    Neurosurgery; 2020 May; 86(5):742-751. PubMed ID: 31225627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment.
    Zhou Z; Singh R; Souweidane MM
    Curr Neuropharmacol; 2017; 15(1):116-128. PubMed ID: 27306036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convection enhanced delivery of carmustine to the murine brainstem: a feasibility study.
    Sewing AC; Caretti V; Lagerweij T; Schellen P; Jansen MH; van Vuurden DG; Idema S; Molthoff CF; Vandertop WP; Kaspers GJ; Noske DP; Hulleman E
    J Neurosci Methods; 2014 Dec; 238():88-94. PubMed ID: 25263805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating infusate parameters for direct drug delivery to the brainstem: a comparative study of convection-enhanced delivery versus osmotic pump delivery.
    Rechberger JS; Power EA; Lu VM; Zhang L; Sarkaria JN; Daniels DJ
    Neurosurg Focus; 2020 Jan; 48(1):E2. PubMed ID: 31896090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convection-Enhanced Delivery of Enhancer of Zeste Homolog-2 (EZH2) Inhibitor for the Treatment of Diffuse Intrinsic Pontine Glioma.
    Sasaki T; Katagi H; Goldman S; Becher OJ; Hashizume R
    Neurosurgery; 2020 Nov; 87(6):E680-E688. PubMed ID: 32674144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of histone H3 K27M mutation and post-translational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes.
    Huang T; Garcia R; Qi J; Lulla R; Horbinski C; Behdad A; Wadhwani N; Shilatifard A; James C; Saratsis AM
    Oncotarget; 2018 Dec; 9(98):37112-37124. PubMed ID: 30647848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of an intratumoral cyst on drug distribution by convection-enhanced delivery: case report.
    Ivasyk I; Morgenstern PF; Wembacher-Schroeder E; Souweidane MM
    J Neurosurg Pediatr; 2017 Sep; 20(3):256-260. PubMed ID: 28686124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma.
    Arms LM; Duchatel RJ; Jackson ER; Sobrinho PG; Dun MD; Hua S
    J Control Release; 2024 Jun; 370():835-865. PubMed ID: 38744345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Murine Models and New Developments in H3K27M Diffuse Midline Gliomas.
    Welby JP; Kaptzan T; Wohl A; Peterson TE; Raghunathan A; Brown DA; Gupta SK; Zhang L; Daniels DJ
    Front Oncol; 2019; 9():92. PubMed ID: 30873381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The distribution, clearance, and brainstem toxicity of panobinostat administered by convection-enhanced delivery.
    Singleton WGB; Bienemann AS; Woolley M; Johnson D; Lewis O; Wyatt MJ; Damment SJP; Boulter LJ; Killick-Cole CL; Asby DJ; Gill SS
    J Neurosurg Pediatr; 2018 Sep; 22(3):288-296. PubMed ID: 29856296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combined approach of convection-enhanced delivery of peptide nanofiber reservoir to prolong local DM1 retention for diffuse intrinsic pontine glioma treatment.
    Bellat V; Alcaina Y; Tung CH; Ting R; Michel AO; Souweidane M; Law B
    Neuro Oncol; 2020 Oct; 22(10):1495-1504. PubMed ID: 32301996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience of convection-enhanced delivery (CED) of carboplatin and sodium valproate into the pons for the treatment of diffuse intrinsic pontine glioma (DIPG) in children and young adults after radiotherapy.
    Szychot E; Walker D; Collins P; Hyare H; Shankar A; Bienemann A; Hollingworth M; Gill S
    Int J Clin Oncol; 2021 Apr; 26(4):647-658. PubMed ID: 33575829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children.
    Anderson RC; Kennedy B; Yanes CL; Garvin J; Needle M; Canoll P; Feldstein NA; Bruce JN
    J Neurosurg Pediatr; 2013 Mar; 11(3):289-95. PubMed ID: 23240851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG).
    Gwak HS; Park HJ
    Crit Rev Oncol Hematol; 2017 Dec; 120():111-119. PubMed ID: 29198324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective Drug Delivery in Diffuse Intrinsic Pontine Glioma: A Theoretical Model to Identify Potential Candidates.
    El-Khouly FE; van Vuurden DG; Stroink T; Hulleman E; Kaspers GJL; Hendrikse NH; Veldhuijzen van Zanten SEM
    Front Oncol; 2017; 7():254. PubMed ID: 29164054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H3K27-altered diffuse midline glioma: a paradigm shifting opportunity in direct delivery of targeted therapeutics.
    Rechberger JS; Power BT; Power EA; Nesvick CL; Daniels DJ
    Expert Opin Ther Targets; 2023 Jan; 27(1):9-17. PubMed ID: 36744399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convection-enhanced Delivery of Therapeutics for Malignant Gliomas.
    Saito R; Tominaga T
    Neurol Med Chir (Tokyo); 2017 Jan; 57(1):8-16. PubMed ID: 27980285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.